Direct Antibody Access to the HIV-1 Membrane-Proximal External Region Positively Correlates with Neutralization Sensitivity

被引:79
作者
Chakrabarti, B. K. [1 ,2 ]
Walker, L. M. [2 ]
Guenaga, J. F. [1 ]
Ghobbeh, A. [1 ]
Poignard, P. [1 ,2 ]
Burton, D. R. [1 ,2 ,3 ]
Wyatt, R. T. [1 ,2 ]
机构
[1] Scripps Res Inst, TSRI, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
[3] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; 2F5; MONOCLONAL-ANTIBODY; CD4; BINDING-SITE; SOLUBLE CD4; CONFORMATIONAL-CHANGES; GP120; GLYCOPROTEIN; MEDIATED FUSION; IN-VIVO; GP41;
D O I
10.1128/JVI.00756-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
On the prereceptor-engaged HIV-1 envelope glycoprotein (Env) spike, epitope access by the membrane-proximal external region (MPER)-directed broadly neutralizing antibodies 2F5 and 4E10 remains unresolved. Data on binding to cell surface Env and entry data using primary isolates suggest inaccessibility of the 2F5 and 4E10 epitopes on the viral spike prior to receptor engagement, but trimer gel shift analysis and slow kinetics of shedding induced by 2F5 and 4E10 indicate otherwise. Therefore, it remains unclear if the epitopes themselves are formed in their antibody-bound state (or at least sampled) prior to receptor/coreceptor engagement or if receptor interactions both expose and form the MPER epitopes, presumably in the putative prefusion transitional intermediate. Here, we performed antibody-virus "washout experiments" using both lab-adapted and a panel of clade B primary isolates to analyze MPER accessibility. The neutralization activity of 2F5 and 4E10 against lab-adapted viruses and sensitive and moderately resistant viruses was largely unaffected by relatively rapid antibody-virus washing, suggesting direct interaction with the "static" spike. However, for more neutralization-resistant viruses, the 2F5 and 4E10 antibodies could neutralize only under the "no antibody-virus wash" conditions, implying that the MPER epitopes were not accessible prior to receptor engagement. Accessibility in the washout conditions could be precisely predicted by the relative resistance to neutralization in a standard neutralization format. These data are consistent with a model in which the local MPER antibody epitope conformations may be sampled on the native spike but are occluded to antibody by local steric or distal quaternary constraints adopted by highly resistant HIV-1 isolates.
引用
收藏
页码:8217 / 8226
页数:10
相关论文
共 71 条
[1]   Role of HIV membrane in neutralization by two broadly neutralizing antibodies [J].
Alam, S. Munir ;
Morelli, Marco ;
Dennison, S. Moses ;
Liao, Hua-Xin ;
Zhang, Ruijun ;
Xia, Shi-Mao ;
Rits-Volloch, Sophia ;
Sun, Li ;
Harrison, Stephen C. ;
Haynes, Barton F. ;
Chen, Bing .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) :20234-20239
[2]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[3]   Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions [J].
Binley, JM ;
Cayanan, CS ;
Wiley, C ;
Schülke, N ;
Olson, WC ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5678-5684
[4]   Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41 [J].
Blish, Catherine A. ;
Nguyen, Minh-An ;
Overbaugh, Julie .
PLOS MEDICINE, 2008, 5 (01) :90-103
[5]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[6]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[7]   Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein [J].
Cao, J ;
Sullivan, N ;
Desjardin, E ;
Parolin, C ;
Robinson, J ;
Wyatt, R ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9808-9812
[8]   Oligomeric structure of the human immunodeficiency virus type I envelope protein on the virion surface [J].
Center, RJ ;
Leapman, RD ;
Lebowitz, J ;
Arthur, LO ;
Earl, PL ;
Moss, B .
JOURNAL OF VIROLOGY, 2002, 76 (15) :7863-7867
[9]  
Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI [10.1089/aid.2010.0281, 10.1089/AID.2010.0281]
[10]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684